$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000139681417000024 Filed on August 02, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$70.93M	$69.64M
YoY Change	1.86%	17.74%
Cost Of Revenue	$23.81M	$23.05M
YoY Change	3.29%	21.79%
Gross Profit	$47.12M	$46.59M
YoY Change	1.15%	15.83%
Gross Profit Margin	66.43%	66.9%
Selling, General & Admin	$39.55M	$43.67M
YoY Change	-9.43%	25.66%
% of Gross Profit	83.93%	93.74%
Research & Development	$18.86M	$9.362M
YoY Change	101.41%	156.56%
% of Gross Profit	40.01%	20.1%
Depreciation & Amortization	$3.700M	$3.200M
YoY Change	15.63%	18.52%
% of Gross Profit	7.85%	6.87%
Operating Expenses	$86.71M	$76.08M
YoY Change	13.97%	32.71%
Operating Profit	-$15.78M	-$6.444M
YoY Change	144.88%	-454.46%
Interest Expense	$5.226M	$1.733M
YoY Change	201.56%	-10.67%
% of Operating Profit
Other Income/Expense, Net	-$3.933M	-$1.456M
YoY Change	170.12%	-17.79%
Pretax Income	-$19.71M	-$7.900M
YoY Change	149.53%	-16908.51%
Income Tax	$30.00K	$58.00K
% Of Pretax Income
Net Earnings	-$19.74M	-$7.958M
YoY Change	148.09%	-99575.0%
Net Earnings / Revenue	-27.83%	-11.43%
Basic Earnings Per Share	-$0.49	-$0.21
Diluted Earnings Per Share	-$490.0K	-$215.1K
COMMON SHARES
Basic Shares Outstanding	40.16M shares	37.18M shares
Diluted Shares Outstanding	40.16M shares	37.18M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$382.4M	$162.7M
YoY Change	135.03%	6.27%
Cash & Equivalents	$53.81M	$116.9M
Short-Term Investments	$328.6M	$137.4M
Other Short-Term Assets	$7.500M	$5.800M
YoY Change	29.31%	70.59%
Inventory	$33.60M	$60.92M
Prepaid Expenses
Receivables	$27.47M	$28.65M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$451.0M	$258.0M
YoY Change	74.81%	12.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$103.2M	$99.28M
YoY Change	3.99%	27.6%
Goodwill	$50.94M	$42.75M
YoY Change	19.16%	57.62%
Intangibles
YoY Change
Long-Term Investments		$0.00
YoY Change		-100.0%
Other Assets	$572.0K	$677.0K
YoY Change	-15.51%	-69.94%
Total Long-Term Assets	$154.8M	$142.7M
YoY Change	8.44%	13.83%
TOTAL ASSETS
Total Short-Term Assets	$451.0M	$258.0M
Total Long-Term Assets	$154.8M	$142.7M
Total Assets	$605.7M	$400.7M
YoY Change	51.17%	12.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.39M	$4.614M
YoY Change	125.23%	-65.31%
Accrued Expenses	$46.76M	$38.33M
YoY Change	21.98%	43.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$106.4M
YoY Change	-100.0%	2.41%
Long-Term Debt Due	$300.0K
YoY Change
Total Short-Term Liabilities	$57.51M	$150.4M
YoY Change	-61.77%	3.41%
LONG-TERM LIABILITIES
Long-Term Debt	$269.3M	$0.00
YoY Change
Other Long-Term Liabilities	$17.86M	$14.16M
YoY Change	26.1%	160.01%
Total Long-Term Liabilities	$17.86M	$14.16M
YoY Change	26.1%	160.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$57.51M	$150.4M
Total Long-Term Liabilities	$17.86M	$14.16M
Total Liabilities	$344.7M	$172.3M
YoY Change	100.0%	7.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$386.1M	-$320.1M
YoY Change	20.63%	3.63%
Common Stock	$40.00K	$37.00K
YoY Change	8.11%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares
Shareholders Equity	$261.0M	$228.4M
YoY Change
Total Liabilities & Shareholders Equity	$605.7M	$400.7M
YoY Change	51.17%	12.88%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$19.74M	-$7.958M
YoY Change	148.09%	-99575.0%
Depreciation, Depletion And Amortization	$3.700M	$3.200M
YoY Change	15.63%	18.52%
Cash From Operating Activities	$3.650M	$7.540M
YoY Change	-51.59%	-24.68%
INVESTING ACTIVITIES
Capital Expenditures	-$5.150M	-$8.870M
YoY Change	-41.94%	-39.54%
Acquisitions
YoY Change
Other Investing Activities	-$56.00M	-$10.78M
YoY Change	419.48%	74.72%
Cash From Investing Activities	-$61.15M	-$19.64M
YoY Change	211.35%	-5.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.330M	2.380M
YoY Change	-2.1%	-10.19%
NET CHANGE
Cash From Operating Activities	3.650M	7.540M
Cash From Investing Activities	-61.15M	-19.64M
Cash From Financing Activities	2.330M	2.380M
Net Change In Cash	-55.17M	-9.720M
YoY Change	467.59%	18.68%
FREE CASH FLOW
Cash From Operating Activities	$3.650M	$7.540M
Capital Expenditures	-$5.150M	-$8.870M
Free Cash Flow	$8.800M	$16.41M
YoY Change	-46.37%	-33.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40341550	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	240000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	524000	USD
	pcrx	Collaborative Agreement Fee Payment Period CollaborativeAgreementFeePaymentPeriod	P2Y
CY2013Q4	pcrx	Collaborative Arrangement Agreement Term CollaborativeArrangementAgreementTerm	P5Y
CY2016Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1356000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1713000	USD
CY2017Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	130000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	336000	USD
CY2016Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	299000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	574000	USD
CY2017Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	186000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	392000	USD
CY2016Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	5789000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	12633000	USD
CY2017Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	5741000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	11658000	USD
CY2016Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	437000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	723000	USD
CY2017Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	29000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	83000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2017Q2	pcrx	Contract Termination Fee ContractTerminationFee	7100000	USD
CY2017Q2	pcrx	Contract Termination Fee Current Portion ContractTerminationFeeCurrentPortion	2900000	USD
CY2017Q2	pcrx	Contract Termination Fee Long Term Portion ContractTerminationFeeLongTermPortion	600000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7070000	shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2044000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	241000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	133000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4362000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	284000	USD
CY2017Q1	pcrx	Debt Instrument Conversion Obligation Numberof Trading Days Priorto Dateonwhich Entity Provides Noticeof Redemption DebtInstrumentConversionObligationNumberofTradingDaysPriortoDateonwhichEntityProvidesNoticeofRedemption	P30D
	pcrx	Debt Instrument Conversion Obligation Numberof Trading Days Priorto Dateonwhich Entity Provides Noticeof Redemption DebtInstrumentConversionObligationNumberofTradingDaysPriortoDateonwhichEntityProvidesNoticeofRedemption	P30D
CY2017Q2	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	100000	shares
CY2017Q2	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	300000	USD
CY2017Q2	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1865000	USD
CY2017Q1	pcrx	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTax	29300000	USD
	pcrx	Deferred Tax Liability Convertible Senior Notes Conversion DeferredTaxLiabilityConvertibleSeniorNotesConversion	26500000	USD
	pcrx	Discontinued Operations Assetsremovedfrom Service DiscontinuedOperationsAssetsremovedfromService	2397000	USD
	pcrx	Discontinued Operations Fixed Assetand Inventory Writedown DiscontinuedOperationsFixedAssetandInventoryWritedown	2397000	USD
	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	1865000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	120960000	USD
CY2016Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	33700000	USD
CY2016Q2	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-7900000	USD
CY2017Q2	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	52100000	USD
	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	4206000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-11722000	USD
CY2017Q2	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-19713000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-39549000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2017Q2	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	662000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	-2294000	USD
	pcrx	Milestone Payments Incurred But Not Yet Paid MilestonePaymentsIncurredButNotYetPaid	8000000	USD
	pcrx	Milestone Payments Incurred But Not Yet Paid MilestonePaymentsIncurredButNotYetPaid	0	USD
CY2016	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	3871000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	4206000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	995000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1056000	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
	pcrx	Total Changein Discontinued Operations Balance TotalChangeinDiscontinuedOperationsBalance	2397000	USD
CY2017Q2	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	27000000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7511000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	10392000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29937000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27467000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37261000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	46755000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37510000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42656000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-30000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-64000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	565207000	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	647206000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	70930000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	-126326000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14744000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7665000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16155000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7345000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14744000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	D
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6836000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5512000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6320000	shares
CY2017Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	375000	USD
	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	375000	USD
CY2016Q4	us-gaap	Assets Assets	391466000	USD
CY2017Q2	us-gaap	Assets Assets	605745000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	243089000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	450991000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56984000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25309000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35944000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53814000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37480952	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40318129	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37480952	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40318129	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	40000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7869000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11622000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19725000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39643000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2017Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	319000	USD
CY2016Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	108738000	USD
CY2017Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	269328000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	23053000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	43331000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	23811000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	48392000	USD
CY2017Q1	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	300000	USD
CY2017Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2500000	shares
CY2017Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	10000	shares
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.3
CY2016Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0722
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0722
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8658000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10551000	USD
CY2017Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0770
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2796000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2470000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	3200000	USD
	us-gaap	Depreciation Depreciation	6300000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	3700000	USD
	us-gaap	Depreciation Depreciation	6800000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6381000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6813000	USD
CY2017Q2	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	2605000	USD
CY2016Q2	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2017Q2	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-4495000	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-4495000	USD
CY2017Q2	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	5000000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.01
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2030000	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3700000	USD
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3732000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	46737000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	50943000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7526000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11025000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-18950000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-38269000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7900000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11722000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19713000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39549000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-374000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-697000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-763000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1280000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-729000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2324000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2045000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1480000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-92000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1849000	USD
CY2016Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	700000	USD
CY2017Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	1733000	USD
	us-gaap	Interest Expense InterestExpense	3601000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	5226000	USD
	us-gaap	Interest Expense InterestExpense	7815000	USD
	us-gaap	Interest Paid InterestPaid	1926000	USD
	us-gaap	Interest Paid InterestPaid	2384000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7915000	USD
CY2017Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13763000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	31278000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	33602000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11742000	USD
CY2017Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	13626000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11621000	USD
CY2017Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6213000	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	324000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	576000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1224000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1738000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	172490000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	344697000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	391466000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	605745000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44838000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	57510000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-31675000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	17870000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5422000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	219194000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-41517000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-204986000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4420000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3662000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-7958000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11812000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-19743000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39609000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1456000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3024000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3933000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9720000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	76084000	USD
	us-gaap	Operating Expenses OperatingExpenses	143812000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	86714000	USD
	us-gaap	Operating Expenses OperatingExpenses	170046000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6444000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8698000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-15780000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-29829000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	35413000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1207000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	6389000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	8272000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8063000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	7545000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3937000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	624000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	572000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	89000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	190000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	18000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-34000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	89000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	190000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	18000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-34000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18914000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17859000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	80000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	89000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15921000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8771000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	121790000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	274791000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9277000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7480000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	345000000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	100065000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	82782000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4431000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2613000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	138526000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	145895000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101016000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103239000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	118191000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9362000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18855000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18856000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35487000	USD
CY2016Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	1140000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	2225000	USD
CY2017Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	1389000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	2611000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346238000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-386134000	USD
CY2016Q2	us-gaap	Revenues Revenues	69640000	USD
	us-gaap	Revenues Revenues	135114000	USD
CY2017Q2	us-gaap	Revenues Revenues	70934000	USD
	us-gaap	Revenues Revenues	140217000	USD
CY2016Q2	us-gaap	Royalty Revenue RoyaltyRevenue	597000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1212000	USD
CY2017Q2	us-gaap	Royalty Revenue RoyaltyRevenue	665000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1317000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	67687000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	132189000	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	70139000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	138564000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43669000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	81626000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39552000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	81672000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	365000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7665000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16155000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7345000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14744000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.98
CY2017Q2	us-gaap	Share Price SharePrice	47.7
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	136653000	USD
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	35745	shares
CY2017Q2	us-gaap	Short Term Investments ShortTermInvestments	328628000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	120960000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1056000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2613000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	218976000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	261048000	USD
CY2017Q2	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	365000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	66000	USD
CY2017Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	44000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37181000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37101000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40160000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39079000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37181000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37101000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40160000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39079000	shares

Files In Submission

Name	View Source	Status
0001396814-17-000024-index-headers.html	Edgar Link	pending
0001396814-17-000024-index.html	Edgar Link	pending
0001396814-17-000024.txt	Edgar Link	pending
0001396814-17-000024-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
paciralogoa06.jpg	Edgar Link	pending
pcrx-20170630.xml	Edgar Link	completed
pcrx-20170630.xsd	Edgar Link	pending
pcrx-20170630_cal.xml	Edgar Link	unprocessable
pcrx-20170630_def.xml	Edgar Link	unprocessable
pcrx-20170630_lab.xml	Edgar Link	unprocessable
pcrx-20170630_pre.xml	Edgar Link	unprocessable
pcrx-63017xex311.htm	Edgar Link	pending
pcrx-63017xex312.htm	Edgar Link	pending
pcrx-63017xex321.htm	Edgar Link	pending
pcrx-63017xex322.htm	Edgar Link	pending
pcrx-6302017x10xq.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2017 Q2 Form 10-Q Financial Statement

#000139681417000024 Filed on August 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2017 Q2 Form 10-Q Financial Statement

#000139681417000024 Filed on August 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx